MTUM·iShares MSCI USA Momentum Factor ETF

MTUM is tightening its AI‑chip tilt as recent moves across its top holdings signal a surge in demand and capital intensity. AVGO’s $30 billion Apple custom‑silicon pact is poised to lift high‑margin AI and data‑center chip sales by several hundred million dollars over the next 12–18 months, reinforcing its position in the high‑margin AI and data‑center chip market. META’s launch of Muse Spark 1.1 and its plan to begin in‑house AI chip production in September reduce supply‑chain risk and open a new developer‑API revenue stream, while the $9 billion Canadian data‑center build further supports its expanding AI infrastructure. NVDA’s valuation reset after a May high keeps the core AI and data‑center demand narrative intact, and the company’s ecosystem link to AVGO suggests GPU demand could rise with Apple launches, especially if China eases restrictions on advanced AI chip imports. MSFT’s severance package adds short‑term expense pressure, but its $2.5 billion Frontier Company and expanding Azure AI services should offset margin concerns and accelerate AI adoption, particularly as the firm embeds agentic AI across consumer‑health operations. LLY’s GLP‑1 uptake provides a non‑AI diversification, with rising prescription volume expected to lift sales growth over the next few weeks, offering a counterbalance to the ETF’s chip‑heavy bias. Across these holdings, the common driver is a surge in AI‑chip demand reshaping earnings growth, capital spending, and supply‑chain realignment, with Apple product launches likely accelerating demand for AVGO silicon and NVDA GPUs. Second‑order effects include regulatory updates on AI chip imports, interest‑rate sensitivity affecting AI‑chip expansion costs, and potential shifts in AI monetization strategy that could ripple through the portfolio. Traders should monitor upcoming earnings releases from AVGO, META, NVDA, MSFT, and LLY, Apple product launches, and any regulatory announcements on AI chip imports over the next 1–10 trading days.